Have a personal or library account? Click to login
The Impact of Body Mass Index on Disease Progression in Ankylosing Spondylitis Cover

References

  1. Alkan, B. M., Fidan, F., Erten, S., Aksekili, H., Alemdar, A., Eroglu, E., Ardicoglu, O., Tosun, A. (2013). Fatigue and correlation with disease-specific variables, spinal mobility measures, and health-related quality of life in ankylosing spondylitis. Mod. Rheumatol., 23 (6), 1101–1107.10.3109/s10165-012-0800-0
  2. Calin, A., Jones, S. D., Garrett, S. L., Kennedy, L. G. (1995). Bath Ankylosing Spondylitis Functional Index. Brit. J. Rheumatol.,34, 793–794.10.1093/rheumatology/34.8.7937551671
  3. Davies, H., Brophy, S., Dennis, M., Cooksey, R., Irvine, E., Siebert, S. (2013). Patient perspectives of managing fatigue in Ankylosing Spondylitis, and views on potential interventions: A qualitative study. BMC Musculoskel. Disord.,14, 163.10.1186/1471-2474-14-163366814923659344
  4. Dernis-Labous, E., Messow, M., Dougados, M. (2003). Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology,42, 1523–1528.10.1093/rheumatology/keg42113130145
  5. de Winter, J. J., van Mens, L. J., van der Heijde, D., Landewe, R., Baeten, D. L. (2016). Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: A meta-analysis. Arthritis Res. Ther.,18, 196.10.1186/s13075-016-1093-z500971427586785
  6. Doran, M. F., Brophy, S., MacKay, K., Taylor, G., Calin, A. (2003). Predictors of long-term outcome in ankylosing spondylitis. J. Rheumatol.,30, 316–320.
  7. Durcan, L., Wilson, F., Conway, R., Cunnane, G., O’Shea, F.D. (2012). Increase body mass index in ankylosing spondylitis is associated with greater burden of symptoms and poor perceptions of the benefits of exercise. J. Rheumatol.,39 (12), 2310–2314.10.3899/jrheum.12059523070993
  8. Exarchou, S., Lindstrom, U., Askling, J., Eriksson, J. K., Forsblad-d’Elia, H., Neovius, M., Turesson, C., Kristensen, L. E., Jacobsson, L. T. H. (2015). The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: A nationwide register study. Arthritis Res. Ther.,17, 118.10.1186/s13075-015-0627-0442488625956915
  9. Garrett, S., Jenkinson, T., Kennedy, L. G., Whitelock, H., Gaisford, P., Calin, A. (1994). A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J. Rheumatol.,21, 2286–2291.
  10. Gremese, E., Bernardi, S., Bonazza, S., Nowik, M., Peluso, G., Massara, A., Tolusso, B., Messuti, L., Miceli, M., C., Zoli, A., Trotta, F., Govoni, M., Ferraccioli, G. (2014). Body weight, gender and response to TNF-a blockers in axial spondyloarthritis. Rheumatology,53, 875–881.10.1093/rheumatology/ket43324407233
  11. Heuft-Dorenbosch, L., van Tubergen, A., Spoorenberg, A., Landewe, R., Dougados, M., Mielants, H., van der Tempel, H., van der Heijde, D. (2004). The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum.,51, 154–159.10.1002/art.2023315077254
  12. Jenkinson, T. R., Mallorie, P. A., Whitelock, H. C., Kennedy, L. G., Garrett, S. L., Calin, A. (1994). Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J. Rheumatol.,21, 1694–1698.
  13. Kim, S. K., Choe, J. Y., Lee, S. S., Shin, K. (2017). Body mass index is related with the presence of syndesmophyte in axial spondyloarthritis: Data from the Korean College of Rheumatology BIOlogics (KOBIO) registry. Mod. Rheumatol.,13, 1–7.10.1080/14397595.2016.126563727919202
  14. Kim, T. J., Lee, S., Joo, K. B., Park, D. J., Park, Y. W., Lee, S. S., Kim, T. H. (2014). The presence of peripheral arthritis delays spinal radiographic progression in ankylosing spondylitis: Observation Study of the Korean Spondyloarthropathy Registry. Rheumatology,53, 1404–1408.10.1093/rheumatology/keu01424609061
  15. Maas, P., Arends, S., van der Veer, E., Wink, F., Efde, M., Bootsma, H., Brouwer, E., Spoorenberg, A. (2016). Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome. J. Rheumatol.,43 (2), 383–387.10.3899/jrheum.15064826669924
  16. Machado, P., Landewé, R., Lie, E., Kvien, T. K., Braun, J., Baker, D., van der Heijde, D. (2011). Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut-off values for disease activity states and improvement scores. Ann. Rheum. Dis.,70, 47–53.10.1136/ard.2010.13859421068095
  17. Maffetone, P. B., Rivera-Dominguez, I., Laursen, P. B. (2017). Overfat and underfat: new terms and definitions long overdue. Front. Public Health,4, 279.10.3389/fpubh.2016.00279520623528097119
  18. Ottaviani, S., Allanore, Y., Tubach, F., Forien, M., Gardette, A., Pasquet, B., Palazzo, E., Meunier, M., Hayem, G., Job-Deslandre, C., Kahan, A., Meyer, O., Dieude, P. (2012). Body mass index influences the response to infliximab in ankylosing spondylits. Arthritis Res.Ther.,14, R115.10.1186/ar3841344649222584116
  19. Rosas, J., Linares-Tello, F., Senabre-Callego, J. M., Barber-Valles, X., Santos-Soler, G., Salas-Heredia, E., Pons Bas, A., Cano Perez, C., Garcia-Carrasco, M. (2017). Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis. Clin. Exp. Rheumatol.,35 (1), 145–148.
  20. Rudwaleit, M., Haibel, H., Baraliakos, X., Listing, J., Märker-Hermann, E., Zeidler, H., Braun, J., Sieper, J. (2009). The early disease stage in axial spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum.,60, 717–727.10.1002/art.2448319248087
  21. Sieper, J., Appel, H., Braun, J., Rudwaleit, M. (2008). Critical Appraisal of Assessment of Structural Damage in Ankylosing Spondylitis. Arthritis Rheum.,58, 649–656.10.1002/art.2326018311819
  22. Stolwijk, C., van Onna, M., Boonen, A., van Tubergen, A. (2016). Global prevalence of spondyloarthritis: A systematic review and meta-regression analysis. Arthritis Care Res.,68 (9), 1320–1331.10.1002/acr.2283126713432
  23. van der Linden, S., Valkneburg, H. A., Cats, A. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum.,27, 361–368.10.1002/art.17802704016231933
  24. Vargas, R. R., van den Berg, R., van Lunteren, M., Ez-Zaitouni, Z., Bakker, P. A. C., Dagfinrud, H., Ramonda, R., Landewe, R., Molenaar, E., van Gaalen, F. A., van der Heijde, D. (2016). Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis? Data from the SPACE cohort. RMD Open,2, e000283.
  25. World Health Organization. Obesity and overweight. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed 12 February 2017).
  26. Zhang, X., Ding, W. (2016). Association of genetic variants in pentraxin 3 gene with ankylosing spondylitis. Med. Sci. Monit., 22, 2911–2916.10.12659/MSM.896562499901527538101
DOI: https://doi.org/10.1515/prolas-2018-0002 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 23 - 28
Submitted on: Mar 2, 2017
|
Accepted on: Jul 19, 2017
|
Published on: Feb 10, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2018 Jūlija Zepa, Inita Buliņa, Vladimirs Lavrentjevs, Ilze Vīnkalna, Liene Ņikitina-Zaķe, Daina Andersone, Aivars Lejnieks, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.